Affordable Inhalers and Nebulizers Act of 2025
Summary
The Affordable Inhalers and Nebulizers Act of 2025 aims to reduce patient cost-sharing for prescription inhaler products used to treat breathing disorders like asthma and chronic obstructive pulmonary disease (COPD). It amends the Public Health Service Act, the Internal Revenue Code, and the Employee Retirement Income Security Act. The bill sets a maximum cost-sharing of $15 per 30-day supply for specified inhaler products under private insurance, Medicare, and creates a payment program for uninsured individuals.
Expected Effects
The act will likely decrease the financial burden on individuals with asthma and COPD who rely on inhalers and nebulizers. This could lead to improved adherence to prescribed treatments and better health outcomes. It also mandates that cost-sharing counts towards deductibles and out-of-pocket maximums.
Potential Benefits
- Reduced out-of-pocket costs for inhalers and nebulizers, making them more affordable.
- Improved access to essential medications for individuals with respiratory conditions.
- Financial relief for uninsured individuals through a payment program.
- Cost-sharing counts towards deductibles and out-of-pocket maximums, providing additional financial protection.
- Potentially better health outcomes due to increased adherence to prescribed treatments.
Potential Disadvantages
- Increased healthcare costs may be shifted to other areas, potentially raising premiums for everyone.
- The $15 cost-sharing limit may still be a burden for some low-income individuals.
- The payment program for uninsured individuals is subject to the availability of appropriations, creating uncertainty.
- Potential administrative burden for healthcare providers to comply with the new regulations.
- The definition of 'specified inhaler product' could be subject to interpretation, leading to disputes.
Most Disadvantaged Areas:
Constitutional Alignment
The bill aligns with the Constitution's general welfare clause (Preamble). Congress has the power to tax and spend to provide for the general welfare of the United States. The bill's provisions relating to health insurance regulation may be viewed under the Commerce Clause (Article I, Section 8), as health insurance is an economic activity that crosses state lines.
Impact Assessment: Things You Care About ⓘ
This action has been evaluated across 19 key areas that matter to you. Scores range from 1 (highly disadvantageous) to 5 (highly beneficial).